Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JS001 in MSI-H Advanced or Recurrent Colorectal Cancer
NCT04118933Phase 2Unknown
- Start
- Jul 2019
- Primary completion
- Jul 2020
- Modality
- Immune Checkpoint Inhibitors, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of toripalimab in colorectal cancer (CRC). Status: unknown.
02
Drugs
toripalimab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT04118933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04118933.